We are actively working with our in-country distribution networks to accelerate the country-by-country approval process to provide Viread and Truvada at substantially reduced prices.

Click here to download the registration status for Viread and Truvada.

For updates on the registration status for Atripla in the developing world, please contact our commercialization partner, Merck & Co, Inc.

Next >>